Tech Company Financing Transactions
Heartflow Funding Round
Bain Capital Life Sciences, Capricorn Investment Group and Fidelity Management & Research Company invested in a $98 million funding round for Heartflow. The round was announced on 3/27/2025.
Transaction Overview
Company Name
Announced On
3/27/2025
Transaction Type
Venture Equity
Amount
$98,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the convertible notes financing will support research and development efforts to further support Heartflow's continued advancement of the coronary computed tomography angiography (CCTA)+Heartflow pathway as the definitive standard for the non-invasive diagnosis and management of CAD.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1400 Seaport Blvd. Bldg B
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Non-invasive coronary artery disease detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dana Mead
Chief Medical Officer
Campbell Rogers
Chief Technical Officer
Charles Taylor
VP - Bus. Development
Lance Scott
VP - General Counsel
Noemi Espinosa
VP - Human Resources
Renata Naoumov
Browse more venture capital transactions:
Prev: 3/27/2025: BuildVision venture capital transaction
Next: 3/27/2025: Connectivity Wireless venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs